secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-07-24T21:00:13+00:00
Accession:  0001193125-26-316225
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Medical Group GC Mary Ann Moore to depart Oct 31; David Haddock appointed successor
--------------------------------------------------------------------------------

- Mary Ann Moore will transition to advisory role until October 31, 2026, then leave the company.
- Separation agreement with PMG Services; termination without cause triggers benefits under employment agreement.
- David Haddock appointed Executive Vice President, General Counsel and Secretary effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526316225/0001193125-26-316225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526316225/md-20260721.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-316225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer